With HPV Vaccine Decline in Sales in US Due to Side Effects, Drug Companies Look to Poor Countries for New Market
What to Do if Your Drug Has Too Many Dangerous Side Effects? Simple—you ship it to third world countries! The manufacturers of two human papillomavirus (HPV) vaccines, Merck (Gardasil) and GlaxoSmithKline (Cervarix), have found a new market: they struck a deal to offer their HPV vaccines to developing countries at much reduced prices. They hope that by 2020, 30 to 40 million girls in developing countries will be getting vaccinated.